Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 631 AL 645

The potential of acupuncture in the treatment of Alzheimer's disease: An exploration from traditional Chinese medicine to modern technology

Wang M, Zhang L, Huang W, Huang J, Luo Y, Huang N.

Complement Ther Med. 2025 Oct;93:103222. doi: 10.1016/j.ctim.2025.103222. Epub 2025 Jul 30.

The APOE Gene Cluster in Normal Aging

Florczak-Wyspiańska J, Hurła M, Pikor D, Poszwa J, Korczowska-Łącka I, Szymanowicz O, Pluto-Prądzyńska A, Goutor U, Wiszniewska M, Kozubski W, Dorszewska J.

J Integr Neurosci. 2025 Jul 28;24(7):36401. doi: 10.31083/JIN36401.

A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies

Hering H, Bussiere T, Liu CC, Glajch KE, Weihofen A, Grogan J, Walsh DM.

Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.

Histone Deacetylase 2 in Alzheimer's Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting

Asadi K, K R, Satarker S, Gurram PC.

Mol Neurobiol. 2025 Dec;62(12):16489-16511. doi: 10.1007/s12035-025-05264-y. Epub 2025 Aug 8.

From particulates to pathways: environmental exposures and their impact on Alzheimer's disease

Liu B, Ahmad MA, Abbas G, Ahmed U, Javed R, Ali I, Ao Q, Deng X.

Brain Res. 2025 Oct 15;1865:149880. doi: 10.1016/j.brainres.2025.149880. Epub 2025 Aug 8.

Gut microbial metabolites and the brain-gut axis in Alzheimer's disease: A review

Ji X, Wang J, Lan T, Zhao D, Xu P.

Biomol Biomed. 2025 Aug 11;26(2):240-250. doi: 10.17305/bb.2025.12921.

Resveratrol as a Therapeutic Agent in Alzheimer's Disease: Evidence from Clinical Studies

Puranik N, Kumari M, Tiwari S, Dhakal T, Song M.

Nutrients. 2025 Aug 5;17(15):2557. doi: 10.3390/nu17152557.

Revisiting APOE: Insights from rare variants and the expanding landscape of Alzheimer's disease genetics

Gim J.

J Alzheimers Dis. 2025 Oct;107(4):1409-1410. doi: 10.1177/13872877251366662. Epub 2025 Aug 17.

Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differences

Shwab EK, Pathak GA, Harvey J, Belloy ME, Fischer CE, Lutz MW, Scholz SW, Cook N, Reid DM, Chen J, Guan DX, Oliveira F, Sinclair LI, Imo U, Creese B, Chiba-Falek O; Neuropsychiatric Syndromes Professional Interest Area Multiomics Work Group, Alzheimer's Association, International Society to Advance Alzheimer's Research and Treatment, Chicago, Illinois, USA.

Alzheimers Dement. 2025 Aug;21(8):e70549. doi: 10.1002/alz.70549.

[Donanemab, an Amyloid β-targeting Antibody for Early Symptomatic Alzheimer's Disease: Summary of Clinical Study Results]

Sato S, Iwata A, Ishii K, Kamiki E, Nishimoto T.

Brain Nerve. 2025 Aug;77(8):907-920. doi: 10.11477/mf.188160960770080907.

[The mechanism of PI3K/AKT pathway in Alzheimer's disease and the research progress of acupuncture intervention]

Chen YZ, Wei YT, Xiao M, Xie WT, Yan XK.

Zhen Ci Yan Jiu. 2025 Aug 25;50(8):965-973. doi: 10.13702/j.1000-0607.20240371.

Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer's disease

Wasim R.

Inflammopharmacology. 2025 Sep;33(9):5273-5289. doi: 10.1007/s10787-025-01916-6. Epub 2025 Aug 27.

Nanoparticles as an Encouraging Therapeutic Approach to Alzheimer's Disease

Koga-Batko J, Antosz-Popiołek K, Nowakowska H, Błażejewska M, Kowalik EM, Beszłej JA, Leszek J.

Int J Mol Sci. 2025 Aug 10;26(16):7725. doi: 10.3390/ijms26167725.

Honey as a Neuroprotective Agent: Molecular Perspectives on Its Role in Alzheimer's Disease

Navarro-Hortal MD, Romero-Márquez JM, Ansary J, Hinojosa-Nogueira D, Montalbán-Hernández C, Varela-López A, Quiles JL.

Nutrients. 2025 Aug 8;17(16):2577. doi: 10.3390/nu17162577.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias